Photocure - Better patient outcomes for patients who received Hexvix®
Oslo, Norway, 30 April 2019: Photocure ASA announced today that a study published in World Journal of Urology, shows that patients who undergo bladder tumor resection with Blue Light Cystoscopy (BLC™) with Hexvix® exhibit improved outcomes even if they progress to disease stages which require radical cystectomy.Beneficial long-term impact of BLC with Hexvix was published in an article by Renninger et al. in World Journal of Urology: The prognostic impact of hexaminolevulinate‑based bladder tumor resection in patients with primary non‑muscle invasive bladder cancer treated with radical